title: The development of angioedema in a patient with type 2 diabetes due to a novel dipeptidyl peptidase-IV inhibitor, anagliptin.
authors: Department of Internal Medicine, National Center for Global Health and Medicine Kohnodai Hospital, Chiba, Japan.
authors: Hidetaka
authors: H
authors: Hamasaki
authors: Hidekatsu
authors: H
authors: Yanai
mesh_terms: D000799:Angioedema / Q000139:chemically induced*; D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy*; D054873:Dipeptidyl-Peptidase IV Inhibitors / Q000009:adverse effects* / Q000627:therapeutic use; D006801:Humans; D008297:Male; D008875:Middle Aged; D011743:Pyrimidines / Q000009:adverse effects* / Q000627:therapeutic use
chemical_list: D054873:Dipeptidyl-Peptidase IV Inhibitors; D011743:Pyrimidines; C583175:anagliptin
keywords: Anagliptin; Angioedema; Dipeptidyl peptidase-IV inhibitor; Type 2 diabetes